How to select the right patient registry for your clinical trial

Patient registries, sometimes called patient databases, are a useful tool in any clinical trial patient recruitment strategy. They help researchers identify potential study participants who meet trial eligibility requirements and have already expressed willingness to participate in research. In addition, they assist with ensuring that the patient pool is representative of the population being studied.

With so many registries available, it can be challenging to know which one might work best for your particular study. Several factors determine whether a given registry will reliably support recruitment for a specific study. Understanding these variables upfront avoids friction later in the enrollment process.

Key Takeaways

Alignment: Match the registry to your specific study design, especially for rare diseases or genetic requirements.
Data Integrity: Prioritize registries with high data quality, completeness, and frequent update cycles.
Compliance: Ensure the provider meets global standards including GDPR, HIPAA, FDA, and EMA regulations.
Usability: Evaluate the platform's ease of use for researchers and the transparency of its cost model.

What to consider when selecting a patient registry

Study design and patient population: Consider if you need specific genetic data, age ranges, or comorbidity tracking.
Data quality and completeness: Verify that demographics and medical histories are accurate and regularly updated.
Data privacy and security: Confirm compliance with GDPR and HIPAA, ensuring all data is encrypted.
Accessibility and ease of use: Look for user-friendly interfaces that allow for efficient searching and data retrieval.
Cost: Assess whether a per-patient, flat fee, or subscription model fits your budget.
Regulatory compliance: Ensure the registry meets FDA and EMA requirements for use in clinical research.

Conclusion

If you’ve decided to use a patient registry as part of your clinical trial patient recruitment strategy, it’s critical to select the organization you partner with thoughtfully. For clinical operations and development teams, registry selection should be evaluated against the specific demands of the study: genetic eligibility complexity, data completeness at the variant level, compliance across relevant jurisdictions, and the feasibility of integrating registry data into existing screening and qualification workflows. Selecting a registry that meets these criteria reduces the risk of enrollment delays, data integrity issues, and regulatory complications. In parallel, it provides a participant pool that accurately reflects the population your trial is designed to study.

For sponsors running precision medicine trials, Sano integrates patient identification, genetic qualification, and long-term engagement into a single platform. This means recruitment is measurable, recontact is compliant, and eligibility confirmation is embedded from the start. Get in touch to discuss your program.